Open original FDA record ↗Recall record
- FDA identifier
- Z-0232-2015
- Company in FDA record
- Biomerieux
- FDA classification date
- Nov 19, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
The products have a wrong expiration date on their labeling, 5 years instead of 2 years.
Source facts
- Action
- Consignees of bioMrieux, impacted by the identified issue, were notified of the FSCA and corrective action (FSCA notification) electronically on October 16th, 2014. Additionally, the bioMrieux United States subsidiary notified US consignees of the FSCA notification via FedEx on October 23rd, 2014.
- Initiated
- 2014-10-16
- Root cause
- Labeling Change Control
- Terminated
- 2017-11-30
- Distribution
- Worldwide Distribution-US (nationwide) including DC and the states of AL, AK, AR, AZ, CA, CO, DE, FL, GA, IA, IN, KY, MA, MD, MI, MO, NC, NE, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI, and the countries of Australia, Austria, China, Czech Republic, France, Germany, India, Italy, Japan, Netherlands, Poland, Portugal, Switzerland, Sweden, Turkey, United Kingdom, Egypt, Pakistan, Slovenia and Uruguay.
- Recall number
- Z-0232-2015
- Recall status
- Terminated
- CDRH record ID
- 130985
- FDA classified
- 2014-11-19
- Recall event number
- 69579